Cours Avant Diagnostics Inc
Actions
US05350M1062
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Michael Ruxin
CEO | Chief Executive Officer | 78 | 01/12/17 |
Thomas Chilcott
DFI | Director of Finance/CFO | 56 | 24/09/20 |
Glenn D. Hoke
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 25/05/18 |
Michael Ruxin
CEO | Chief Executive Officer | 78 | 01/12/17 |
Director/Board Member | 43 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
-18,16% | 11,13 Md | |
+58,43% | 3,6 Md | |
-31,31% | 2,26 Md | |
-14,31% | 2,16 Md | |
-26,61% | 1,54 Md | |
+34,35% | 1,17 Md | |
-3,28% | 744 M | |
-22,75% | 482 M | |
-40,20% | 432 M |